Vimarsana
Biggest News Aggregation in the World

Page 3 - Vickyb Gregg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vickyb Gregg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vickyb Gregg Today - Breaking & Trending Today

Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.18 EPS - Vimarsana News

Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.18 EPS

Quest Diagnostics (NYSE:DGX – Get Free Report) released its earnings results on Tuesday. The medical research company reported $2.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.18, Briefing.com reports. The firm had revenue of $2.37 billion during the quarter, compared to the consensus estimate of $2.29 billion. Quest Diagnostics […]

Source: wkrb13.com
Quest Diagnostics (NYSE:DGX) Price Target Raised to $145.00 - Vimarsana News

Quest Diagnostics (NYSE:DGX) Price Target Raised to $145.00

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price boosted by investment analysts at Citigroup from $135.00 to $145.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Citigroup’s target price suggests a potential upside of 5.27% from the company’s previous […]

Source: wkrb13.com
Quest Diagnostics (NYSE:DGX) Releases FY24 Earnings Guidance - Vimarsana News

Quest Diagnostics (NYSE:DGX) Releases FY24 Earnings Guidance

Quest Diagnostics (NYSE:DGX – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $8.72-$8.97 for the period, compared to the consensus earnings per share estimate of $8.75. The company issued revenue guidance of $9.40-$9.48 billion, compared to the consensus revenue estimate of […]

Quest Diagnostics (NYSE:DGX) Posts Quarterly Earnings Results, Beats Estimates By $0.18 EPS - Vimarsana News

Quest Diagnostics (NYSE:DGX) Posts Quarterly Earnings Results, Beats Estimates By $0.18 EPS

Quest Diagnostics (NYSE:DGX – Get Free Report) announced its quarterly earnings data on Tuesday. The medical research company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.18, Briefing.com reports. Quest Diagnostics had a net margin of 9.23% and a return on equity of 15.79%. The firm had revenue […]

Source: wkrb13.com
Citigroup Raises Quest Diagnostics (NYSE:DGX) Price Target to $145.00 - Vimarsana News

Citigroup Raises Quest Diagnostics (NYSE:DGX) Price Target to $145.00

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by research analysts at Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. Citigroup’s price target suggests a potential upside of 5.27% from the company’s current […]